LIVIA ZALEWSKI: Open Payments
NPI 1356608921 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 56 payments from 23 companies in 2025. Trend: 2023 $934 · 2024 $668 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| Corcept Therapeutics | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Ardelyx, Inc. | 3 | $68 |
| ACADIA Pharmaceuticals Inc | 3 | $68 |
| Lundbeck LLC | 3 | $55 |
| Alpha Cognition USA, Inc. | 1 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
Products named: Kerendia, Korlym, VRAYLAR, REXULTI, IBSRELA, NUPLAZID, Zunveyl, CAPLYTA.
Industry payments across LA — which companies pay providers there.
